0
     

Report Added
Report already added
Global Clinical Trial Management Systems Market

Global Clinical Trial Management Systems Market

Report Scope:

This report examines the current and forecasted market potential for clinical trial management systems. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for clinical trial management systems based on the product, deployment and delivery mode.

The clinical trial management systems product market is segmented into software and services. The clinical trial management systems deployment market is segmented into enterprise-based CTMS and site-based CTMS. The clinical trial management systems delivery market is segmented into web-based, cloud-based and on-premises services.

The clinical trial management systems market has been geographically segmented into Europe, North America, the Asia-Pacific (APAC) region and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China are regional segments. For market estimates, data are provided for 2020 as the base year, and then forecast form 2021 through year-end 2026. Estimated values are based on clinical trial management systems companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

- 32 tables
- An overview of the global markets for clinical trial management systems
- Estimation of the market size and analyses of market trends, with data from 2019 to 2020, estimates for 2021 and projection of CAGR through 2026
- Quantification of clinical trial management systems market based on product type, deployment, delivery mode and region, and analysis of market drivers, restraints and other forces impacting the global market
- Highlights of the current and future market potential and insights into government initiatives, regulatory framework and reimbursement scenario
- Detailed description of the advanced technologies for clinical trial management systems and discussion on how they are advantageous to pharmaceuticals, biotech and other research-focused life sciences organizations
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Advarra, Calyx, DatStat, Medidata and Oracle

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Highlights of the Market for Clinical Trial Management Systems
Chapter 3 Market Background
Introduction
Need for CTMS
CTMS
CTMS Features
CTMS Benefits
CTMS versus EDC
Chapter 4 Market Dynamics
Market Drivers
Increased Outsourcing of Clinical Trials
Growing Number of Clinical Trials
Rising R&D Expenditure of Biopharma Companies
Increasing Prevalence of Chronic Diseases
Market Restraints
Unreliable and Inaccurate Data
Complex and Poorly-Integrated Systems
Regulatory Barriers and Approval Delays
Chapter 5 Impact of the COVID-19 Pandemic
Introduction
Outbreak
Impact of COVID-19 on Clinical Trial Management Systems
Chapter 6 Market Breakdown by Product
Introduction
Software
Market Size and Forecast
Market Analysis
Services
Market Size and Forecast
Market Analysis
Chapter 7 Market Breakdown by Deployment
Introduction
Enterprise-Based CTMS
Market Size and Forecast
Market Analysis
Site-Based CTMS
Market Size and Forecast
Market Analysis
Chapter 8 Market Breakdown by Delivery Mode
Introduction
Web-Based
Market Size and Forecast
Market Analysis
Cloud-Based
Market Size and Forecast
Market Analysis
On-premise
Market Size and Forecast
Market Analysis
Chapter 9 Market Breakdown by Region
Introduction
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World
Chapter 10 Competitive Landscape
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches, Achievements and Partnerships
Chapter 11 Company Profiles
ADVARRA
BSI BUSINESS SYSTEMS INTEGRATION AG
CALYX
CLARIO
DATSTAT (R1 COMPANY)
DATATRAK INT
ENNOV
MEDIDATA SOLUTION INC. (DASSAULT SYSTEMES)
ORACLE
REALTIME SOFTWARE SOLUTIONS LLC
VEEVA SYSTEMS INC.
List of Tables
Summary Table : Global Market for Clinical Trial Management Systems, by Product, Through 2026
Table 1 : Global Market for Clinical Trial Management Systems, by Product, Through 2026
Table 2 : Global Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 3 : Global Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 4 : Global Market for Clinical Trial Management Systems, by Region, Through 2026
Table 5 : North American Market for Clinical Trial Management Systems, by Country, Through 2026
Table 6 : North American Market for Clinical Trial Management Systems, by Product, Through 2026
Table 7 : North American Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 8 : North American Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 9 : European Market for Clinical Trial Management Systems, by Country, Through 2026
Table 10 : European Market for Clinical Trial Management Systems, by Product, Through 2026
Table 11 : European Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 12 : European Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 13 : Asia-Pacific Market for Clinical Trial Management Systems, by Country, Through 2026
Table 14 : Asia-Pacific Market for Clinical Trial Management Systems, by Product, Through 2026
Table 15 : Asia-Pacific Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 16 : Asia-Pacific Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 17 : RoW Market for Clinical Trial Management Systems, by Product, Through 2026
Table 18 : RoW Market for Clinical Trial Management Systems, by Deployment, Through 2026
Table 19 : RoW Market for Clinical Trial Management Systems, by Delivery Mode, Through 2026
Table 20 : Global Manufacturer Market Shares of Clinical Trial Management Systems, 2020
Table 21 : Advarra: Clinical Trial Management Systems Product Portfolio
Table 22 : BSI Business Systems Integration AG: Clinical Trial Management Systems Product Portfolio
Table 23 : Calyx: Clinical Trial Management Systems Product Portfolio
Table 24 : Clario: Clinical Trial Management Systems Product Portfolio
Table 25 : DatStat: Clinical Trial Management Systems Product Portfolio
Table 26 : Datatrak Int.: Clinical Trial Management Systems Product Portfolio
Table 27 : Ennov: Clinical Trial Management Systems Product Portfolio
Table 28 : Medidata Solution Inc.: Clinical Trial Management Systems Product Portfolio
Table 29 : Oracle: Clinical Trial Management Systems Portfolio
Table 30 : RealTime Software Solutions LLC: Clinical Trial Management Systems Portfolio
Table 31 : Veeva Systems Inc.: Clinical Trial Management Systems Portfolio

Report Title: Global Clinical Trial Management Systems Market


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline